Skip to main content
. 2011 Mar 7;2:37. doi: 10.3389/fmicb.2011.00037

Table 1.

Forward oligonucleotides used in this study for the mutagenesis of the sor gene; the corresponding reverse-complimentary oligonucleotides required for the Quikchange method (Stratagene) are not shown.

Oligonucleotide name Oligonucleotide sequence* Comment*
DelK fwd CCGACTTCACTGCAGTTGTAggaggtggaATTC Replacement of aa 139-148 with two
CAGTTATTTCACAACC Gly residues; Addition of EcoRI site
DelL fwd CAAACATGCCTATAAACACTGGGggtggaATTT Replacement of aa 129-151 with two additional
CACAACCATATGGAAA Gly residues; Removal of PstI site
R99A fwd GGAGTTACTTATTCgcgCTATGCTATTCATGCGC Addition of Bsh1236I site
R99IL fwd AACTGGAGcTACTTATTCmtcCTATGCTATTCATG Addition of AluI site
S226A fwd AACCCTGGAgCACTTGAGCCcGATCCAAAT Removal of PsuI site
S226T fwd AACCCTGGAaCACTTGAGCCcGATCCAAAT Removal of PsuI site
S226IL fwd AACCCTGGamtACTTGAGCCcGATCCAAAT Removal of PsuI site
MM296/297 fwd** ATTAAATCCAryGryGGAAGGCACcTTCTGGAG- Addition of BanI site
F133A fwd TGAAATGACCGACgcaAtTGCGGTTGTA Addition of MunI site, double mutant; T134I
F141A fwd GTAGGAAAGAAGgcaGCAGAAGGAAAGCCT Removal of PstI site
H166A fwd GCCTTTGCAGAGgcgTCAGTAATTCC Removal of Bsp1286I site
H277A fwd TAAGACAAGTAgctGACGAAGTTTT Removal of TatI site

*Underlined, restriction sites specified in the comments column.

**Multiple mutants: M297 A, M296V, MM296/7VT, and MM296/7TT.